Fujifilm names North Carolina as location for $2 billion large-scale cell manufacturing site
CDMO subsidiary Fujifilm Diosynth Biotechnologies will operate the site which is expected to be operational in 2025
Fujifilm says it has chosen Holly Springs in North Carolina as the location for its new 200 billion yen ($2 billion) large-scale cell culture manufacturing site in the US, which the Japanese firm describes as the largest end-to-end cell culture biopharmaceutical facility in North America.
Fujifilm’s CDMO subsidiary, Fujifilm Diosynth Biotechnologies (FDB) will operate the site, which will host large-scale cell culture manufacturing of bulk drug substance production with 8 x 20,000L bioreactors, with additional 24 x 20,000L bioreactor capacity earmarked, based on market demand.
The facility will also provide commercial scale, automated fill-finish and assembly, packaging, and labelling services. It will employ 725 workers by the end of 2028 and is expected to be operational by spring 2025.
In a statement, Fujifilm said that after a “rigorous data-driven” evaluation process, “Holly Springs…was selected for its strong pool of technical talent, local resources and partners with the right competencies, clean energy resources, and sustainability for future growth.”
FDB already has a facility in Morrisville, North Carolina as well as other development and manufacturing plants in the US, the UK and Denmark.
At the start of this year, Fujifilm announced it was investing 4 billion yen ($40 million) in FDB to build a new process development and manufacturing facility for viral vectors and advanced therapies in the greater-Boston area, which is scheduled to begin process development operation this autumn.
Related News
-
News Women in Pharma: Moving beyond discussions and into best practice at CPHI Milan
In this second CPHI Milan special of our monthly series, we cover the key takeaways from the Diversity & Wellbeing track held on October 10, 2024. -
News AstraZeneca invests in AI collaboration for cancer drug trials
The British-Swedish pharmaceutical giant is partnering with biotechnology firm Immunai Inc to increase the efficiency of some cancer drug trials. -
News Ozempic and Wegovy prices questioned as Novo Nordisk faces US Senate hearing
The CEO of Novo Nordisk was grilled during a US Senate committee hearing on September 24, 2024, in which the exorbitant prices of the Danish company’s blockbuster drugs Ozempic and Wegovy were called into question. -
News The BIOSECURE Act: implications for the pharma supply chain
On September 9, 2024, the US House of Representatives voted to pass the bill titled the BIOSECURE Act (the Act), which lists several Chinese companies in the pharmaceutical supply chain. The Act will prohibit American companies from contracting or doin... -
News On Track at CPHI Milan: Thermo Fisher Scientific Track Sponsor interview
With CPHI Milan just around the corner, we sat down with some of the sponsors for this year’s conference tracks to discuss the most pressing topics in pharma. -
News CPHI Milan Speaker Spotlight: Pharma Manufacturing and Localisation in Africa
In the run-up to CPHI Milan, we sit down with some of the experts and thought-leaders speaking at this year’s conferences. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Eli Lilly licenses rheumatoid arthritis manufacturing in Africa
American pharmaceutical company Eli Lilly has signed a partnership with Egyptian organisation Eva Pharma to localise manufacturing of rheumatoid arthritis treatments in Africa.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance